Copenhagen IBD Center

03/10/2022

PhD Project in computer-aided abdominal procedures Department of Computer Science Faculty of SCIENCE University of Copenhagen

03/10/2022

𝗢𝗽𝗲𝗻 𝗖𝗮𝗹𝗹 𝗳𝗼𝗿 𝗣𝗵𝗗 𝗙𝗲𝗹𝗹𝗼𝘄𝘀𝗵𝗶𝗽 𝗶𝗻 𝗠𝗮𝗰𝗵𝗶𝗻𝗲 𝗟𝗲𝗮𝗿𝗻𝗶𝗻𝗴 𝗮𝗻𝗱 𝗜𝗕𝗗

In collaboration with Copenhagen University Department of Computer Science, we are looking for candidates for a PhD position with a qualification in data science. The PhD position is centred around developing new computer sciences methods within imaging and structured data for the better good of patients with inflammatory bowel disease. The prerequisites for all projects during the PhD will be, if the results are satisfying, translated to daily medical work and be beta-tested with the potential to upscale the end product.
If you are interested, see the link below for further information.

PhD Project in computer-aided abdominal procedures Department of Computer Science Faculty of SCIENCE University of Copenhagen

28/06/2022

We are very proud to be part of the Center for Intestinal Immune Regulation (CIIR) led by William Agace, that has just received funding from the Novo Nordisk Foundation Challenge program!

With this collaboration, Johan Burisch and Flemming Bendtsen together with all members of CIIR, hope to bring new important knowledge about the pathogenesis of inflammatory bowel disease that can improve treatment and prognosis prediction.

One research team will convert wastewater sludge into a valuable raw material that can be used in for example building materials. The material can replace oil-based raw material and thereby contribute to a circular economy. A second team will take a unique scientific approach to creating soft, comfo...

17/06/2022

Meet Christoph Norden, our new consultant at CPH-IBD. Christoph is the head consultant for paediatric gastroenterology at our Department of Paediatrics. During the last year, he has been responsible for children and adolescents with IBD in Region Zealand. Christoph is a specialist in paediatrics and further specialized in paediatric gastroenterology. Furthermore, he is a committee member of DASPGHAN (Danish Society for Paediatric Gastroenterology, Hepatology and Nutrition) and of the gastroenterology group of the Danish Paediatric Society.

Welcome, Christoph!



______________________________________________________________________

Mød Christoph Norden, som er vores nye overlæge i CPH-IBD. Christoph er ansat på børne- og ungeafdelingen hvor han er fagområdeansvarlig overlæge for pædiatrisk gastroenterologi. Det sidste året har Christoph været IBD-ansvarlig overlæge for børn og unge i Region Sjælland. Christoph er speciallæge i pædiatri og er ekspertuddannet i pædiatrisk gastroenterologi. Han er medlem af bestyrelsen i DASPGHAN (Danish Society for Paediatric Gastroenterology, Hepatology and Nutrition), samt repræsentant i Dansk Pædiatrisk Selskabs gastroenterologi-udvalg.

Velkommen, Christoph!

13/06/2022

Endoscopic small bowel dilation has emerged as a minimally invasive, bowel-preserving therapeutic approach for patients with stricturing Crohn’s disease during the last 20 years.

Mads Wewer, John Karstensen and Johan Burisch have published Danish nationwide registry data describing the use and efficacy of this intervention. They show an increasing use over the study period, 1997-2015, and that it is efficient in both patients with primary- and post-surgical strictures. The 5-year failure rates were 25% and 29%, respectively.

Can we make better use of the potential of this treatment option in the future?

­­­­­­­­­­­­­­­______________________________________________________________________

Endoskopisk tyndtarmsdilatation er en non-invasiv, tarmbesparende behandlingsmulighed til patienter med Crohns sygdom og stenoser/forsnævringer i tyndtarmen, der har været tilgængelig de sidste 20 år.

Mads Damsgaard Wewer, John Gásdal Karstensen og Johan Burisch har netop publiceret et nationalt dansk kohortestudie, som beskriver udbredelsen og effektivitet af denne intervention. De fandt en stigning i anvendelsen af endoskopisk tyndtarmsdilatation i periode, 1997-2015. Behandlingen var effektivt ved både primære og post-kirurgiske stenoser og 5 år efter behandlingen havde hhv 25% og 29% oplevet behandlingssvigt.

Kan vi udnytte potentialet ved denne behandlingsmulighed bedre i fremtiden?

s with small bowel strictures. Methods This nationwide cohort comprised individuals ≥18 years old, diagnosed with Crohn’s disease in Denmark between 1 January 1997 and 31 December 2015, according to the National Patient Registry (NPR). Results The cohort consisted of 9737 incident Crohn’s di...

23/05/2022

Don’t forget the mouth!

Patients with inflammatory bowel disease (IBD) have a significantly increased risk for worse oral health and periodontitis, and Crohn’s disease patients seem more severely affected, including losing more teeth. Furthermore, periodontitis is associated with increased disease activity and IBD-related disability. IBD patients should be kept under close surveillance to prevent periodontitis development and/or mitigate its progression and its calamities.

Together with Kristina Bertl, Nikolaus Pandis, Corinna Bruckmann, Björn Klinge, Andreas Stavropoulos, Gorm Roager Madsen, and Johan Burisch we have recently published two papers investigating oral health and periodontitis in patients with IBD. We surveyed more than 1,000 patients as well as more than 3,000 controls. Thank you to all the participants as well as the Danish patient organization Colitis-Crohn Foreningen.

https://lnkd.in/e62BVM5x
https://lnkd.in/ewJWqYg3

_______________________________________________________________________
Glem ikke munden!

Patienter med inflammatorisk tarmsygdom (IBD) har en øget risiko for dårlig mundsundhed og periodontitis (tandkødsbetændelse). Det gælder især patienter med Crohn’s sygdom, som er hårdere ramt og hyppigere mister tænder deraf. Derudover er periodontitis forbundet med øget sygdomsaktivitet og IBD-relateret invalidering. Det er derfor vigtigt at patienter med IBD også spørges ind til mundsundhed for at periodontitis kan opdages og behandles.

Sammen med Kristina Bertl, Nikolaus Pandis, Corinna Bruckmann, Björn Klinge, Andreas Stavropoulos, Gorm Roager Madsen og Johan Burisch har vi netop publiceret 2 artikler, der undersøger mundsundhed og periodontitis hos mere end 1,000 patienter og over 3,000 kontrolpersoner. Tak til alle deltagere og til Colitis-Crohn Foreningen.

27/04/2022

Meet Signe, how is our new consultant at !

Signe Wildt is head consultant of the outpatient clinic of Gastroenterology. Her ph.d and research has primarily focused on the inflammatory bowel disease microscopic colitis, and she is active in and member of the Board in the European Microscopic Colitis Group (EMCG). She has experience with participation in several industry sponsored studies evaluating the efficacy of new IBD drugs.

Signe is a member of the Board in the Danish Society of Gatroenterology and Hepatology (DSGH), and national representative in European Crohn's and Colitis Organisation (ECCO).

----------------
Mød Signe, som er vores nye overlæge i !
Signe Wildt er afsnitsansvarlig overlæge for det medicinske ambulatorium i Gastroenheden. Hendes ph.d og forskning har primært haft fokus på forskellige aspekter af tarmsygdommen mikroskopisk colitis, og hun er aktiv i og medlem af bestyrelsen i European Microscopic Colitis Group(EMCG). Har gennem tiden deltaget i flere industri-initierede forskningsprojekter med afprøvning af ny medicin til IBD-patienter.

Signe er medlem af bestyrelsen i Dansk Selskab for Gastroenterologi og Hepatologi (DSGH), samt dansk repræsentant i European Crohn's and Colitis Organisation (ECCO).

Amager og Hvidovre Hospital Gastroenheden Hvidovre Hospital@

06/03/2022

The Faroe Islands has the highest incidence of IBD in the world for reasons that we do not fully understand. Together with Amanda Vang, Marjun Á Fríðriksmørk Berbisá, Kári Rubek Nielsen, Johan Burisch the rest of the Faroese IBD team, we have found that the gut bacterial composition of Faroese IBD patients was similar to healthy controls which is in contrast to what we usually expect to find when comparing IBD patients to controls. More research into the genetics and environmental factors in Faroe Islands are warranted and we are very happy to be part of this ongoing collaboration

AbstractBackground. The Faroe Islands has the world’s highest incidence of inflammatory bowel disease (IBD). Epidemiological studies have characterized this uni

04/01/2022

How will monitoring of our IBD patients look in the future?

We are proud to have contributed to this paper published today in Gastroenerology as part of the IBD special issue. Thank you to Rune Wilkens, Michael Dolinger, Johan Burisch and Christian Maaser.

The paper is available without a paywall, we hope that you find it interesting.

Breaking through the biologic therapy efficacy plateau for inflammatory bowel disease requires the strategic development of personalized biomarkers in…

19/12/2021

Did you know that up to 50% of patients with inflammatory bowel diseases discontinued biological treatment within the first year?

Mirabella Zhao and Johan Burisch, in collaboration with Morten Sall Jensen, Jakob Kjellberg, Torben Knudsen, Jens Kelsen and Mehmet Coskun evaluated trends in the use of biological treatment among patients with inflammatory bowel diseases and their outcomes in a nationwide Danish study.

Their findings show a decline in surgery rates and costs paralleled by increasing and earlier use of biological treatment. However, persistence rates for first-line biological treatment remained low meaning that many patients needed to change their therapy due to loss of response. This clearly demonstrates that many patients do not have their needs met by current therapies are not perfect and that the many new drugs coming to the clinic in the near future are very much needed.

https://lnkd.in/dezMkk7Y

15/11/2021

Are patients with inflammatory bowel disease at increased risk of COVID-19 and of long-term effects following COVID-19?

We are proud to be part of the Danish COVID-IBD study group, that recently has published long-term data from our national cohort. Mohamed Attauabi and colleagues found no association between the use of medications and the severity of COVID-19. But a large proportion of our cohort experienced long-term effects.

----------------------------
Har patienter med inflammatorisk tarmsygdom større risiko for at få COVID-19 og at få senfølger?

Vi er stolte af at være en del af det Danske COVID-IBD projekt, der for nylig har offentliggjort langtidsdata fra vores nationale kohorte. Mohamed Attauabi har sammen med resten af gruppen bl.a. vist at der ikke var sammenhæng mellem den medicinske behandling for inflammatorisk tarmsygdom og sværhedsgraden af COVID-19. Anddelen af patienter, der oplevede senfølger efter COVID-19 er dog stor.

Johan Burisch Anja Poulsen Marianne Kajbæk Vester-Andersen August Pilegaard Prahm Klaus Theede

AbstractBackground and Aims. The health consequences of the coronavirus disease 2019 (COVID-19) among patients with ulcerative colitis (UC) and Crohn’s disease

05/11/2021

Mød Ida Vind, som er lægefaglig leder på det sengeafsnit, hvor patienter med inflammatorisk tarmsygdom (IBD) er indlagt, når behovet opstår.

Hun er med til at gøre overgangen fra børne-ungeafdelingen til voksenafdelingen så uproblematisk som muligt for de unge patienter med IBD. Deres tilfredshed og velvære er vores højeste prioritet.

Endvidere er hun medansvarlig for industriinitierede forskningsprojekter indenfor IBD, med test af nye lægemidler til IBD-patienter.

Hendes forskningsinteresse er hovedsageligt indenfor epidemiologien blandt IBD-patienter.
____
Meet Ida Vind, who is the medical responsible at the inpatient ward for patients with inflammatory bowel diseases (IBD).

She is also involved in making the transition from the child-adolescent section to the adult section as smooth as possible for the young patients with IBD. Their satisfaction and well-being are of highest priority.

Furthermore, she is co-responsible for industry-initiated research projects within IBD, with testing of new drugs for IBD patients.

Her research of interest is primarily in epidemiology in IBD.
Colitis-Crohn Foreningen Amager og Hvidovre Hospital